ArticleiLIVER2024

Comment on "Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab".

Binghua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.